封面
市场调查报告书
商品编码
1392016

放射性示踪剂市场:按类型、按应用、按最终用户、按地区

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球放射性示踪剂市场规模预计将从 2023 年的 32.4 亿美元增至 2030 年的 52.6 亿美元,预测期内复合年增长率为 7.2%。

报告范围 报告详情
基准年 2022年 2023年市场规模 32.4亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 7.20% 2030年市场规模预测 52.6亿美元
图 1. 2023 年放射性示踪剂的全球市场占有率(按地区划分)
放射性示踪剂市场-IMG1

放射性示踪剂已成为许多行业的重要工具,包括医学、研究和石油探勘。这些示踪剂由发射辐射的放射性物质组成,可以轻鬆检测和测量。这些用于追踪特定分子的运动,研究各种生物过程,并确定地下蕴藏量的潜在来源。近年来,随着放射性示踪剂在医疗诊疗、环境领域、石化领域的应用不断扩大,全球放射性追踪剂市场出现了显着成长。

市场动态:

全球放射性示踪剂市场的成长是由技术进步、慢性病盛行率增加以及个人化医疗需求不断增长等多种因素所推动的。市场越来越多地采用正子断层扫描(PET) 和单光子发射断层扫描(SPECT) 等诊断影像技术,这些技术利用放射性追踪剂来检测和分析各种疾病和状况,因此取得了显着的增长。

市场面临诸如有关放射性材料的使用和处置的严格规定等挑战。监管机构制定了严格的指导方针,以确保放射性示踪剂的安全处理和处置,这显着增加了製造成本并影响了市场成长。熟练专业人员的有限和与核医学程序相关的高成本预计将限制市场成长。

儘管有这些挑战,全球放射性示踪剂市场仍充满成长机会。放射性药物製造技术新兴市场的发展和新放射性同位素市场的开拓预计将为市场相关人员提供新的机会。此外,石油和天然气探勘、环境监测和工业检查等行业越来越多地采用放射性示踪剂,预计也将进一步推动市场成长。

例如,2023年3月16日,製药公司Telix Pharmaceuticals Limited.宣布,美国食品药物管理局(FDA)已核准Illuccix(镓镓)68戈泽托肽注射的补充新药认证申请(sNDA)准备套件) 。

本研究的主要特点

  • 该报告对全球放射性示踪剂市场进行了详细分析,并提出了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了不同细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数,介绍了全球放射性示踪剂市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 全球放射性示踪剂市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球放射性示踪剂市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 慢性病盛行率增加
    • 放射性药物的半衰期短
    • 肿瘤学的新应用
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球放射性追踪剂市场-冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球放射性示踪剂市场,依类型,2023-2030

  • 介绍
  • 诊断放射性示踪剂
  • 治疗性放射性示踪剂
  • 其他的

第六章 全球放射性示踪剂市场,依应用划分,2023-2030 年

  • 介绍
  • 肿瘤学
  • 心臟病学
  • 神经病学
  • 甲状腺
  • 整形外科
  • 内分泌学
  • 其他的

第 7 章 全球放射性示踪剂市场,依最终使用者划分,2023-2030 年

  • 介绍
  • 医院
  • 专科诊所
  • 诊断中心
  • 学术研究所
  • 其他的
  • 2018-2030年市场规模及预测、与前一年同期比较成长率

第八章全球放射性示踪剂市场,按地区,2023-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章竞争形势

  • PerkinElmer Inc.
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6389

Global radioactive tracer market size is expected to reach US$ 5.26 Bn by 2030, from US$ 3.24 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.24 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.20% 2030 Value Projection: US$ 5.26 Bn
Figure 1. Global Radioactive Tracer Market Share (%), By Region, 2023
Radioactive Tracer Market - IMG1

Radioactive tracers have become an essential tool in several industries including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. These are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to increasing applications of radioactive tracers in medical diagnostics and treatment, and in the environmental and petrochemical sectors.

Market Dynamics:

Global radioactive tracer market growth is driven by several factors including technological advancements, increasing prevalence of chronic diseases, and growing demand for personalized medicine. The market is witnessing significant growth due to rising adoption of diagnostic imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) that utilize radioactive tracers to detect and analyze various diseases and conditions.

The market faces certain challenges such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, wand this significantly increases the cost of production and affects the market growth. The limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain the market growth.

Despite these challenges, global radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new opportunities for market players. Moreover, increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is expected to drive the market growth further.

For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.

Key features of the study:

  • This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global radioactive tracer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include PerkinElmer Inc., Cardinal Health, Bracco, NTP Radioisotopes, Nordion (Canada) Inc., Curium, IRE, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes, LLC, Lantheus Holdings, Inc., Eckert & Ziegler, Siemens Healthineers, GE Healthcare, Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., and Sumitomo Heavy Industries, Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market

Detailed Segmentation:

  • By Type
    • Diagnostic Radioactive Tracers
    • Therapeutic Radioactive Tracers
    • Others
  • By Application
    • Oncology
    • Cardiology
    • Neurology
    • Thyroid
    • Orthopedic
    • Endocrinology
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Academic & Research Institutes
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Global Radioactive Tracer Market:
    • PerkinElmer Inc.
    • Cardinal Health
    • Bracco
    • NTP Radioisotopes
    • Nordion (Canada) Inc.
    • Curium
    • IRE
    • Telix Pharmaceuticals Limited
    • NorthStar Medical Radioisotopes, LLC
    • Lantheus Holdings, Inc.
    • Eckert & Ziegler
    • Siemens Healthineers
    • GE Healthcare
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Radioactive Tracer, By Type
    • Market Radioactive Tracer, By Application
    • Market Radioactive Tracer, By End User
    • Market Radioactive Tracer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of chronic diseases
    • Short half-life of radiopharmaceuticals
    • Emerging applications in oncology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Radioactive Tracer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Radioactive Tracer Market, By Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Therapeutic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Radioactive Tracer Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Thyroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Radioactive Tracer Market, By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Radioactive Tracer Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,( US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Analyst Views

10. Section

  • Research Methodology
  • About us